Clinical Trial

Alpha-Synuclein PET/CT in Various α-Syn-Related Disease

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the potential usefulness of 18F-FIAT-2, 18F-C05-05, 18F-SPAL-T-06 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various α-Syn-related disease patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-22.
Trial Details
NCT Number NCT06949670
Lead Sponsor Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital
Conditions Alpha Synuclein Pathology, Alpha-Synuclein, Parkinson Disease
Enrollment 500 participants
Start Date 2025-04-01
Primary Completion 2028-04-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-29